Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 5
2006 2
2007 4
2008 4
2009 6
2010 6
2011 10
2012 13
2013 9
2014 7
2015 4
2016 7
2017 7
2018 5
2019 8
2020 10
2021 9
2022 20
2023 15
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean wanfang chen (2 results)?
Targeting renal cell carcinoma with a HIF-2 antagonist.
Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, Zhang H, Chang J, Gardner KH, Bruick RK, Reeves C, Hwang TH, Courtney K, Frenkel E, Sun X, Zojwalla N, Wong T, Rizzi JP, Wallace EM, Josey JA, Xie Y, Xie XJ, Kapur P, McKay RM, Brugarolas J. Chen W, et al. Nature. 2016 Nov 3;539(7627):112-117. doi: 10.1038/nature19796. Epub 2016 Sep 5. Nature. 2016. PMID: 27595394 Free PMC article.
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma.
Yang W, Xing X, Yeung SJ, Wang S, Chen W, Bao Y, Wang F, Feng S, Peng F, Wang X, Chen S, He M, Zhang N, Wang H, Zeng B, Liu Z, Kidane B, Seder CW, Koyanagi K, Shargall Y, Luo H, Peng S, Cheng C. Yang W, et al. Among authors: chen w. J Immunother Cancer. 2022 Jan;10(1):e003497. doi: 10.1136/jitc-2021-003497. J Immunother Cancer. 2022. PMID: 35022193 Free PMC article.
Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Gui CP, Chen YH, Zhao HW, Cao JZ, Liu TJ, Xiong SW, Yu YF, Liao B, Cao Y, Li JY, Huang KB, Han H, Zhang ZL, Chen WF, Jiang ZY, Gao Y, Han GP, Tang Q, Ouyang K, Qu GM, Wu JT, Guo JP, Li CX, Li PX, Liu ZP, Hsieh JT, Cai MY, Li XS, Wei JH, Luo JH. Gui CP, et al. Lancet Digit Health. 2023 Aug;5(8):e515-e524. doi: 10.1016/S2589-7500(23)00095-X. Epub 2023 Jun 29. Lancet Digit Health. 2023. PMID: 37393162 Free article.
Segmental Membranous Glomerulopathy in Adults.
Zhu S, Liu X, Yue S, Luo B, Song Z, Xu X, Wang L, Hou X, Li K, Liang Q, Zhou Z, Chen W, Zheng L. Zhu S, et al. Among authors: chen w. Kidney Dis (Basel). 2023 Aug 8;9(6):507-516. doi: 10.1159/000533294. eCollection 2023 Dec. Kidney Dis (Basel). 2023. PMID: 38089441 Free PMC article.
The role of 18F-FDG PET/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma.
Wang X, Yang W, Zhou Q, Luo H, Chen W, Yeung SJ, Zhang S, Gan Y, Zeng B, Liu Z, Feng S, Zhang X, Cheng C. Wang X, et al. Among authors: chen w. Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4241-4251. doi: 10.1007/s00259-022-05872-z. Epub 2022 Jun 23. Eur J Nucl Med Mol Imaging. 2022. PMID: 35732974
149 results